RxCelerate, one of the leading out-sourced drug discovery and development platforms in the UK, announced that it has acquired UK-based molecular modelling company Prosarix.
RxCelerate is a rapidly growing out-sourced drug development service provider, based on the Babraham Research Campus.
Address: Building B280 Babraham Research Campus Babraham
Post Code: CB22 3AT
Country: United Kingdom
Membership Type: Corporate 21-50